Search Results - V. L. Doshchitsyn

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Plant stanol ethers in atherosclerosis prevention and treatment (materials of the International Symposium «Heart and Mind», Berlin, October 2006)

    Plant stanol ethers in atherosclerosis prevention and treatment (materials of the International Symposium «Heart and Mind», Berlin, October 2006) by V. L. Doshchitsyn

    Published 2007-02-01

    .

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Arterial hypertension in metabolic syndrome

    Arterial hypertension in metabolic syndrome by V. L. Doshchitsyn, O. M. Drapkina

    Published 2006-10-01

    .

    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem

    Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem by Yu. M. Pozdnyakov, O. N. Miller, S. A. Luchinsky, V. L. Doshchitsyn

    Published 1970-01-01

    Aim. To study clinical effectiveness and safety of propafenone and amiodarone in patients with arterial hypertension (AH), coronary heart disease (CHD), chronic heart failure (CHF) with preserved left ventricular (LV) systolic function, and atrial fibrillation (AF). Material and methods. The study i...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    ANTIARRHYTHMIC THERAPY EFFECTIVENESS AND IMPACT ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION

    ANTIARRHYTHMIC THERAPY EFFECTIVENESS AND IMPACT ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION by O. N. Miller, A. V. Tarasov, Yu. M. Pozdnyakov, S. A. Luchinskyi, V. L. Doshchitsyn

    Published 2011-08-01

    Clinical effectiveness, safety, and the impact on left ventricular (LV) systolic and diastolic function were assessed for Propanorm® and Cordarone® in patients with atrial fibrillation (AF), arterial hypertension (AH), coronary heart disease (CHD), and chronic heart failure (CHF) with preserved ejec...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation

    Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation by A. V. Tarasov, O. N. Miller, Yu. M. Pozdnyakov, S. A. Luchinskyi, V. L. Doshchitsyn

    Published 1970-01-01

    Aim. To study clinical effectiveness, safety, and effects on left ventricular (LV) systolic and diastolic function for Class IC and Class III antiarrhythmic medications — propafenone and amiodarone, respectively — in patients with chronic heart failure (CHF), intact ejection fraction (EF), and atria...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Antiarrhythmic therapy effects on quality of life among patients with extrasystoles

    Antiarrhythmic therapy effects on quality of life among patients with extrasystoles by V. L. Doshchitsyn, O. A. Kramynina, E. V. Chernova, O. B. Karpunichev, O. V. Barysheva, E. Yu. Shatykhina, Yu. V. Bezborodova

    Published 2008-10-01

    To investigate antiarrhythmic therapy effectiveness, safety and impact on quality of life (QoL) among patients with symptomatic extrasystolia, a study was performed in 152 individuals, with 140 completing the study. Mean age of the patients was 57 years; 102 patients sufferedfrom chronic coronary he...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HEART FAILURE WITH INTACT LEFT VENTRICULAR SYSTOLIC FUNCTION

    EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HE... by O. N. Miller, S. A. Starichkov, Yu. M. Pozdnyakov, S. A. Luchinsky, A. V. Tarasov, V. L. Doshchitsyn, O. A. Kramynina, E. G. Volkova, D. L. Ilyinykh

    Published 2010-08-01

    Clinical effectiveness and safety of Propanorm® was studied in patients with arterial hypertension (AH), coronary heart disease (CHD), chronic heart failure (CHF) with intact systolic left ventricular (LV) function, and atrial fibrillation (AF). Effectiveness and safety of Propanorm® was compared to...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: